US Pharma MarketingDuring glucose-monitoring specialist Dexcom's Investor Day on Thursday, CEO Jake Leach announced the release of Dexcom G8, which Leach describes as a "completely new product platform.”
Dexcom unveils next-generation G8 CGM for real-time glucose monitoring
During Dexcom Investor Day, CEO Jake Leach announced the company's newest CGM monitor, G8, which utilizes technology that Dexcom has been developing for decades. During glucose-monitoring specialist Dexcom 's Investor Day on Thursday, CEO Jake Leach announced the release of Dexcom G8, which Leach describes as a "completely new product platform.” "The G8 system has additional technology built in, based on a whole new silicon chip, design and algorithm. Actually, this has been a development for several decades at Dexcom because we've always had this idea of trying to do this, but now we're finally proving the feasibility that we…
Source: MobiHealthNews